R. Torcuator

发表

Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma

T. Mikkelsen, R. Jain, L. Schultz, 2010, Journal of Neuro-Oncology.

Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report

T. Mikkelsen, R. Zuniga, R. Torcuator, 2009, Journal of Neuro-Oncology.

Intraoperative real-time MRI-guided stereotactic biopsy followed by laser thermal ablation for progressive brain metastases after radiosurgery

F. Jolesz, F. Jolesz, A. Golby, 2016, Journal of Clinical Neuroscience.

Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis

T. Mikkelsen, R. Jain, J. Rock, 2009, Journal of Neuro-Oncology.

The role of salvage reirradiation for malignant gliomas that progress on bevacizumab

T. Mikkelsen, R. Jain, L. Schultz, 2010, Journal of Neuro-Oncology.

Retrospective analysis of patterns of recurrence seen on MRI in patients with recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan

T. Mikkelsen, R. Jain, M. Rosenblum, 2008 .

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan

T. Mikkelsen, R. Jain, L. Schultz, 2009, Journal of Neuro-Oncology.

Imaging response criteria for recurrent gliomas treated with bevacizumab: Role of diffusion weighted imaging as an imaging biomarker

T. Mikkelsen, R. Jain, D. Hearshen, 2010, Journal of Neuro-Oncology.

NEURO/MEDICAL ONCOLOGY

Scott N. Hwang, Katrina H. Smith, Susan M. Chang, 2013 .

Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma

T. Mikkelsen, R. Jain, L. Schultz, 2010, Journal of Neuro-Oncology.